Press Release: Thailand Government Pharmaceutical Organization
30 May 2019
The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. And nervous pain Add research to various types of Parkinson’s Alzheimer’s patients.
Today (30 May) at 09.30 hrs. At the Medical Department Ministry of Public Health Dr. Sophon Mektana, advisor to the Minister of Public Health Chairman of the Pharmaceutical Organization Board is the president At the signing ceremony of a memorandum of cooperation on research and development of medical marijuana extract products between the Medical Department and the Pharmaceutical Organization With Dr. Somsak Anakasilp, Director General of the Medical Department And Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization, is the signatory.
Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee
Said that the Pharmaceutical Organization and the Medical Department Has prepared for the use of marijuana for medical use in accordance with the academic principles International standards and get the most benefit Which found that cannabis contains cannabis substances that are active, inhibiting, stimulating, improving the balance of the nervous system Hormones, immunity and other systems of the body, both agencies have collaborated to research and develop marijuana extracts and medical marijuana products to meet the standard quality With a proportion of important substances, THC and CBD, suitable for medical needs Including the study of stability Laboratory research Preclinical research And clinical research As well as academic administration Management of medical marijuana information in various dimensions with systematic information technology Develop personnel in related fields together to make use of medical marijuana. Effective, most effective in treatment Relieve symptoms
Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization
Said that the organization will conduct researchDevelop and produce hemp extracts and medical marijuana products for standard quality With a proportion of important substances, THC and CBD, suitable for medical needs Along with the study of stability and quality assurance of extracts and products For use in laboratory research Preclinical research And clinical research, including the production of 3 drops of hemp oil under the tongue. Formula 1 THC is higher than CBD. Formula 2 CBD is higher than THC and formula 3, THC and CBD 1 to 1 for drops under the tongue ( Sublingual Drop (5 ml. Of 2,500 bottles) produced according to the medical marijuana extract prototype project, Phase 1 at the Government Pharmaceutical Organization, Thanyaburi, in July. And will produce 2,500 bottles continuously every 4 months. In addition, around the beginning of 2020 will begin to produce hemp extracts according to Phase 2 project to expand production capacity into semi-industrial level on the area. 1,000 square meters of the Government Pharmaceutical Organization, Thanyaburi District, Pathum Thani Province, which will be able to produce up to 8 times more cannabis extracts as well as adding a variety of products to suit the medical needs and usage patterns. Of patients, such as rectal suppositories Skin patches The sheet is under the tongue, cream, which can be produced by this product. The organization will focus on the use of special treatment schemes
or special access scheme (SAS), which is a way to treat patients and collect research data simultaneously.
Dr. Somsak Anakasilp, Director-General of the Medical Department
Said that the Department of Medical Affairs will conduct laboratory research Preclinical research And clinical research Including the study of the effectiveness and safety of medical marijuana products of the Government Pharmaceutical Organization To confirm the confidence Have clear academic information Have a reasonable conclusion To maximize the benefits for patients For medical marijuana extracts of the Pharmaceutical Organization will be applied to research with 3 patients. Initially this will focus on research in the form of patients with special access scheme or SAS with patients. Sick group 1. A group that cannabis extract has the benefit of treatment Which has clearly supported academic information, including nausea and vomiting in patients receiving chemotherapyEpilepsy that is difficult to treat in children and resistant epilepsy Muscle contraction in patients with neurological degeneration Neurological pain that uses other treatment methods is not effective. Part 2. A group of diseases that cannabis extracts can benefit in controlling symptoms But must have additional academic information on safety and effectiveness issues Is a study focusing on preclinical research And clinical research such as Parkinson’s disease Alzheimer’s disease, anxiety disorders, patients who need palliative care End-stage cancer patients 3. Cannabis extract may be useful in the treatment of various types of cancer. But must research in vitro and with animals Before researching in humans Which is a complete research study of 3 levels, namely, research studies in preclinical research laboratories And clinical research Hemp extracts may be useful in the treatment of various types of cancer. But must research in vitro and with animals Before researching in humansWhich is a complete research study of 3 levels, namely, research studies in preclinical research laboratories And clinical research Hemp extracts may be useful in the treatment of various types of cancer. But must research in vitro and with animalsBefore researching in humans Which is a complete research study of 3 levels, namely, research studies in preclinical research laboratories And clinical research
“Pharmaceutical Organization And the Department of Medical Services Have shared academic management And effective personnel development in related fields together And support resources such as tools, appliances, materials, laboratory equipment Research tools Examples of cannabis extracts and medical marijuana products for research operations In order to be able to conduct relevant research As well as academic administration And personnel development in related fields With the exchange of academic information and research that has been developed As well as providing cooperation and facilitating collaboration For further benefits to society, “said the Director-General of the Medical Department.
Thank you / Government Pharmaceutical Organization
Call 02 644 8856/082 493 9890
30 May 2019